Article info

PDF
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration

Authors

  1. Correspondence to Professor Cem Gabay, Division of Rheumatology, Geneva University Hospitals, Geneva 1205, Switzerland; cem.gabay{at}hcuge.ch
View Full Text

Citation

Lauper K, Nordström DC, Pavelka K, et al
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration

Publication history

  • Received December 14, 2017
  • Accepted April 24, 2018
  • First published May 5, 2018.
Online issue publication 
August 10, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.